Abstract
Primary central nervous system lymphoma (PCNSL) is commonly lethal, affects vulnerable immunosuppressed populations, and continues to increase in incidence among immunocompetent individuals in several countries. During the last decades, epidemiological studies from different parts of the world have demonstrated varying incidence rates of PCNSL, as well as discrepant findings concerning whether the incidence of PCNSL is increasing or stable. These findings suggest that there may be some factor or factors other than immunodeficiency that either causes or increases the susceptibility of an individual to PCNSL.
Keywords
- Germinal Center
- Mycophenolate Mofetil
- Mycophenolate Mofetil
- Primary Central Nervous System Lymphoma
- Increase Incidence Rate
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Mrugala MM, Rubenstein JL, Ponzoni M, Batchelor TT (2009 Jan) Insights into the biology of primary central nervous system lymphoma. Curr Oncol Rep 11(1):73–80; review
Cady FM, O’Neill BP, Law ME et al (2008) Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. J Clin Oncol 26:4814–4819
Tun HW, Personett D, Baskerville KA et al (2008 Mar 15) Pathway analysis of primary central nervous system lymphoma. Blood 111(6):3200–3210
Blay JY, Conroy T, Chevreau C et al (1998 Mar) High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J Clin Oncol 16(3):864–871
Eby NL, Grufferman S, Flannelly CM et al (1988) Increasing incidence of primary brain lymphoma in the US. Cancer 62:2461–2465
Hochberg FH, Miller DC (1988) Primary central nervous system lymphoma. J Neurosurg 68:835–853
Levitt LJ, Dawson DM, Rosenthal DS, Moloney WC (1980) CNS involvement in the non-Hodgkin’s lymphomas. Cancer 45:545–552
Cote TR, Manns A, Hardy CR et al (1996) Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 88:675–679
Corn BW, Marcus SM, Topham A et al (1997) Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 79:2409–2413
Miller DC, Hochberg FH, Harris NL et al (1994) Pathology with clinical correlations of primary central nervous system non-Hodgkin’s lymphoma. The Massachusetts General Hospital experience 1958–1989. Cancer 74:1383–1397
Olson JE, Janney CA, Rao RD et al (2002) The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95:1504–1510
Lutz JM, Coleman MP (1994) Trends in primary cerebral lymphoma. Br J Cancer 70:716–718
van der Sanden GA, Schouten LJ, van Dijck JA et al (2002) Primary central nervous system lymphomas: incidence and survival in the Southern and Eastern Netherlands. Cancer 94:1548–1556
Makino K, Nakamura H, Kino T et al (2006) Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan. Surg Neurol 66:503–506
Haldorsen IS, Krossnes BK, Aarseth JH et al (2007) Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989–2003: time trends in a 15-year national survey. Cancer 110:1803–1814
Hao D, DiFrancesco LM, Brasher PM et al (1999) Is primary CNS lymphoma really becoming more common? A population-based study of incidence, clinicopathological features and outcomes in Alberta from 1975 to 1996. Ann Oncol 10:65–70
Krogh-Jensen M, D’Amore F, Jensen MK et al (1994) Incidence clinicopathological features and outcome of primary central nervous system lymphomas. Population-based data from a Danish lymphoma registry. Danish Lymphoma Study Group, LYFO. Ann Oncol 5:349–354
Yau YH, O’Sullivan MG, Signorini D et al (1996) Primary lymphoma of central nervous system in immunocompetent patients in south-east Scotland. Lancet 348:890
Au WY, Chan AC, Srivastava G et al (2000) Incidence and pathology of primary brain lymphoma in Hong Kong Chinese patients. Leuk Lymphoma 37:175–179
Powari M, Radotra B, Das A, Banerjee AK (2002) A study of primary central nervous system lymphoma in northern India. Surg Neurol 57:113–116
Tomlinson FH, Kurtin PJ, Suman VJ et al (1995) Primary intracerebral malignant lymphoma: a clinicopathological study of 89 patients. J Neurosurg 82:558–566
Chamberlain MC, Kormanik PA (1999) AIDS-related central nervous system lymphomas. J Neurooncol 43:269–276
Diamond C, Taylor TH, Aboumrad T, Anton-Culver H (2006) Changes in acquired immunodeficiency syndrome-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: incidence, presentation, treatment, and survival. Cancer 106:128–135
Kirk O, Pedersen C, Cozzi-Lepri A et al (2001) Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98:3406–3412
Wolf T, Brodt HR, Fichtlscherer S et al (2005) Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin’s lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 46:207–215
Ammassari A, Cingolani A, Pezzotti P et al (2000) AIDS-related focal brain lesions in the era of highly active antiretroviral therapy. Neurology 55:1194–1200
Besson C, Goubar A, Gabarre J et al (2001) Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98:2339–2344
Haldorsen IS, Krakenes J, Goplen AK et al (2008) AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989–2003. BMC Cancer 8:225
Kasamon YL, Ambinder RF (2005) AIDS-related primary central nervous system lymphoma. Hematol Oncol Clin North Am 19:665–687
Cingolani A, Fratino L, Scoppettuolo G, Antinori A (2005) Changing pattern of primary cerebral lymphoma in the highly active antiretroviral therapy era. J Neurovirol 11 Suppl 3:38–44
O’Neill BP, Kelly PJ, Earle JD et al (1987) Computer-assisted sterotactic biopsy for the diagnosis of primary central nervous system lymphoma. Neurology 37:1160–1164
Mohile NA, Abrey LE (2007) Primary central nervous system lymphoma. Semin Radiat Oncol 17:223–229
Schabet M (1999) Epidemiology of primary CNS lymphoma. J Neurooncol 43:199–201
Snannoudj R, Durrbach A, Leblond V et al (2003) Primary brain lymphomas after kidney transplantation presentation and outcome. Transplantation 76:930–937
O’Neill BP, Vernino S, Dogan A et al (2007) EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetil. Neurooncol 9:364–369
Kleinschmidt-DeMasters BK, Damek DM, Lillehe KO et al (2008) Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. J Neuropathol Exp Neurol 67(11):1103–1111
Ferreri AJ, Reni M (2007) Primary central nervous system lymphoma. Crit Rev Oncol Hematol 63:257–268
Gates AE, Kaplan LD (2002) AIDS malignancies in the era of highly active antiretroviral therapy. Oncology 16:657–665
Nakamura M, Shimada K, Ishida E, Konishi N (2004) Histopathology pathogenesis and molecular genetics in primary central nervous system lymphomas. Histol Histopathol 19:211–219
Paulus W (1999) Classification, pathogenesis and molecular pathology of primary CNS lymphomas. J Neurooncol 43:203–208
Nicholas J (2007) Human herpesvirus 8 encoded proteins with potential roles in virus-associated neoplasia. Front Biosci 12:265–281
Schiff D, Suman VJ, Yang P et al (1998) Risk factors for primary central nervous system non-Hodgkin’s lymphoma (PCNSL). Cancer 82:975–992
DeAngelis LM (1991) Primary central nervous system lymphoma as a secondary malignancy. Cancer 67:1431–1435
Reni M, Ferreri AJ, Zoldan MC, Villa E (1997) Primary brain lymphomas in patients with a prior or concomitant malignancy. J Neurooncol 32:135–142
Pulido JS, Vierkant RA, Olson JE et al (2009 Jun) Racial differences in primary central nervous system lymphoma incidence and survival rates. Neurooncol 11(3):318–322
Camilleri-Broet S, Criniere E, Broet P et al (2006) A uniform activated B-cell-like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases. Blood 107:190–196
Braaten KM, Betensky RA, de Leval L et al (2003) BCL-6 expression predicts improved survival in patients with primary central nervous system lymphoma. Clin Cancer Res 9:1063–1069
Levy O, DeAngelis LM, Fillipa DA et al (2008) Bcl-6 predicts improved prognosis in primary central nervous system lymphoma. Cancer 112(1):151–156
Montesinos-Rongen M, Brunn A, Bentink S et al (2008) Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell. Leukemia 22:400–405
Algazi AP, Kadoch C, Rubenstein JL (2009) Biology and treatment of primary central nervous system lymphoma. Neurotherapeutics 6:587–597
Rubenstein J, Ferreri AJM, Pittaluga S (2008) Primary lymphoma of the central nervous system: epidemiology, pathology and current approaches to diagnosis, prognosis and treatment. Leuk Lymphoma 49:32–51
Thelander EF, Ichimura K, Corcoran M et al (2008) Characterization of 6q deletions in mature B-cell lymphomas and childhood acute lymphoblastic leukemia. Leuk Lymphoma 49(3):477–487
Nakamura M, Kishi M, Sakaki T et al (2003) Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas. Cancer Res 63:737–741
Rubenstein JL, Fridlyand J, Shen A et al (2006) Gene expression and angiotropism in primary CNS lymphoma. Blood 107:3716–3723
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Haldorsen, I.S., O’Neill, B.P. (2012). Epidemiology of Primary Central Nervous System Lymphoma. In: Batchelor, T., DeAngelis, L. (eds) Lymphoma and Leukemia of the Nervous System. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7668-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7668-0_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7667-3
Online ISBN: 978-1-4419-7668-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)